Treatment with PD-1 prior to stem cell transplant is safe for Hodgkin lymphoma patients

(Dana-Farber Cancer Institute) A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news